search
Back to results

Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns (Burns)

Primary Purpose

Burns

Status
Withdrawn
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
50% Oxygen/50% Nitrous oxide premix (KALINOX 170 bar)
50%Oxygen/50% Nitrogen premix
Sponsored by
Air Liquide Santé International
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Burns focused on measuring children with burns, Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care

Eligibility Criteria

4 Years - 15 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care

    • potentially mildly to moderately painful
    • lasting for at least 15 minutes and for less than 30 minutes
    • eligible to receive short-term prophylactic analgesic treatment
    • for whom the consent form has been signed (parent and child)

Exclusion criteria:

  • Child treated under general anaesthesia
  • Child physically or mentally incapable of responding to an assessment of his/her pain on a visual scale.
  • Child suffering from moderate to severe pain when beginning the care procedure (FPSr > 4)
  • Exclusion criteria linked to the product

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    A

    B

    Arm Description

    50% Oxygen/50% Nitrous oxide premix (Kalinox® 170 bar)

    50%Oxygen/50% Nitrogen premix

    Outcomes

    Primary Outcome Measures

    The intensity of the pain was assessed using the "Faces Pain Scale Revised"

    Secondary Outcome Measures

    Full Information

    First Posted
    March 19, 2008
    Last Updated
    January 18, 2012
    Sponsor
    Air Liquide Santé International
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00643357
    Brief Title
    Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns
    Acronym
    Burns
    Official Title
    Study of the Efficacy and Safety of KALINOX® 170 Bar for the Performance of Care Procedures in Children With Burns
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2012
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    No patient recruited due to current guidelines for the pain related to burn
    Study Start Date
    March 2008 (undefined)
    Primary Completion Date
    January 2009 (Actual)
    Study Completion Date
    January 2009 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Air Liquide Santé International

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to assess the efficacy and the safety of Kalinox® 170 bar, over a period of three consecutive care procedures in burned children. It's a international (Spain, France, Tunisia and Belgium) study with 8 investigator centers.
    Detailed Description
    Pain due to burns is one of the most intense and persistent types of pain. This pain consists of a permanent background pain, overlaid by episodes of temporary exacerbations triggered by treatment procedures or burn-care procedures. Care procedures, such as changing the dressings or cleaning the wounds, make it necessary to handle the painful areas, and this causes transient intense pain. Analgesia with a 50/50 mix of nitrous oxide and oxygen is a simple and effective technique, which induces a state of light sedation during which verbal contact is not lost, which is rapidly reversible and is devoid of any major side effects. This gas is used in paediatrics for carrying out painful procedures of a short duration, such as lumbar puncture and minor surgery. The nitrous oxide/oxygen mix has also been used to treat the pain induced by care procedures in children with burns for more than 30 years. The objective of our study is to obtain qualitative and quantitative data about the efficacy of Kalinox® 170 bar in care procedures in children with burns.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Burns
    Keywords
    children with burns, Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigator
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    A
    Arm Type
    Experimental
    Arm Description
    50% Oxygen/50% Nitrous oxide premix (Kalinox® 170 bar)
    Arm Title
    B
    Arm Type
    Placebo Comparator
    Arm Description
    50%Oxygen/50% Nitrogen premix
    Intervention Type
    Drug
    Intervention Name(s)
    50% Oxygen/50% Nitrous oxide premix (KALINOX 170 bar)
    Intervention Description
    gaz flow between 4 to 15 L/min inhalation between 15 to 60 minutes
    Intervention Type
    Drug
    Intervention Name(s)
    50%Oxygen/50% Nitrogen premix
    Intervention Description
    inhalation between 15 to 60 minutes gaz flow between 4 to 15 l/min
    Primary Outcome Measure Information:
    Title
    The intensity of the pain was assessed using the "Faces Pain Scale Revised"
    Time Frame
    Faces Pain Scale Revised

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    4 Years
    Maximum Age & Unit of Time
    15 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care potentially mildly to moderately painful lasting for at least 15 minutes and for less than 30 minutes eligible to receive short-term prophylactic analgesic treatment for whom the consent form has been signed (parent and child) Exclusion criteria: Child treated under general anaesthesia Child physically or mentally incapable of responding to an assessment of his/her pain on a visual scale. Child suffering from moderate to severe pain when beginning the care procedure (FPSr > 4) Exclusion criteria linked to the product

    12. IPD Sharing Statement

    Learn more about this trial

    Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns

    We'll reach out to this number within 24 hrs